搜尋結果
Council Post: The Business Case For Expanding Diversity In Clinical Trials
Forbes· 2 日前By now, you’ve heard why expanding representation in clinical trial populations matters for ...
Med-tech of China gaining popularity
China Daily· 2 日前While taking strides to go global, China's medical technology sector has shown signs of overtaking and leading the world ...
Macrogenics Stock Drops 77% After Study Deaths
The Wall Street Journal· 7 日前MacroGenics shares plunged 77.4% on Friday, erasing $773.2 million in market value, after the ...
prostate 相關
廣告